Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2026-02-22 @ 9:37 AM
Study NCT ID:
NCT02817659
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-03-07
First Post:
2016-06-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Determine Tolerability to Glucagon Infusion in Obese Subjects
Sponsor:
AdventHealth Translational Research Institute
Organization:
Study Overview
Official Title:
A Pilot Study to Determine Tolerability to Glucagon Infusion in Obese Subjects
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2025-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GIO
Brief Summary:
To further understand the tolerability of glucagon.
Detailed Description:
To determine the tolerability of glucagon infusion administered in an escalating step-wise manner in healthy obese subjects
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?: